ÄãºÃ£¬»¶Ó­À´µ½¾­¹ÜÖ®¼Ò [µÇ¼] [×¢²á]

ÉèΪÊ×Ò³ | ¾­¹ÜÖ®¼ÒÊ×Ò³ | Êղر¾Õ¾

ѧÊõÂÛÎĵIJο¼ÎÄÏ×µÄÖøÂ¼¸ñʽ

·¢²¼Ê±¼ä£º2014-09-24 À´Ô´£ºÈË´ó¾­¼ÃÂÛ̳
1 ÆÚ¿¯ÎÄÕÂ ÖøÂ¼¸ñʽ£ºÖ÷ÒªÔðÈÎÕß. ÌâÃû[ÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±êÖ¾]. ¿¯Ãû£¬ Ä꣬ ¾í(ÆÚ) ÆðÒ³-Ö¹Ò³[ÒýÓÃÈÕÆÚ]. »ñÈ¡ºÍ·ÃÎÊ·¾¶. ×¢£ºÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±ê־Ϊµç×ÓÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿£¬ÒýÓÃÈÕÆÚ¡¢»ñÈ¡ºÍ·ÃÎÊ·¾¶ÎªÁª»úÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿¡£ 1.1 ÆÚ¿¯·Ö¾í£¬Á¬Ðø±àÒ³Âë»òÿÆÚµ¥¶À±àÒ³Âë [1] Halpern SD£¬Ubel PA£¬Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med£¬2002£¬347(4) 284-287. [2] ³ÂÃô»ª£¬ÎâÞ±£¬ÑîÞ±£¬µÈ. ³¬ÉùÔìÓ°¶Ô¸Î°©É䯵ÏûÈÚɸѡÊÊÓ¦Ö¤µÄÓ¦ÓüÛÖµ. ÖлªÒ½Ñ§ÔÓÖ¾£¬2005£¬85(49) 3491-3494. [3] Íô¹ú»ª£¬Âí½ø£¬¼¾Êʶ«£¬µÈ. ¼±ÐÔ³öѪ»µËÀÐÔÒÈÏÙÑ×µÄÊÖÊõÖÎÁÆ. Öм¶Ò½¿¯£¬1995£¬30(8) 22-25. 1.2 ÆÚ¿¯²»·Ö¾í [4] Turan I£¬Wredmark T£¬Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop£¬1995(320) 110-114. 1.3 ÆÚ¿¯ÎÞ¾íºÍÆÚ [5] Browell DA£¬Lennard TW. Imunologic status of the cancer patients and the effects of blood transfusion on antitumor responses. Curr Opin Gen Surg£¬1993 325-333. 1.4 ¾íµÄÔö¿¯ [6] ÍôÏþÀ×£¬ÁèÏ飬Áõ×æË´. ¼ÒÍÃÃÔÂ·ÆÆ»µÑÛÕðµçͼÃè¼Ç. Öлª¶ú±ÇÑÊºí¿ÆÔÓÖ¾£¬1995£¬30Ôö¿¯ 13. [7] Geraud G£¬Spierings EL£¬Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache£¬2002£¬42 Suppl 2 S93-99. 1.5 ¾íÖзֲ¿ [8] Abend SM£¬Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal£¬2002£¬83(Pt 2) 491-495. 1.6 ÆÚµÄÔö¿¯ [9] Glauser TA. Integrating clinical trial data into clinical practice. Neurology£¬2002, 58(12 Suppl 7) S6-12. 1.7 ÆÚÖзֲá [10] Ahrar K£¬Madoff DC£¬Gupta S£¬et al. Development of a large animal model for lung tumors. J Vasc Interv Radiol£¬2002£¬13(9 Pt 1) 923-928. 1.8 Á½ÆÚºÏÆÚ [11] Rose ME£¬Huerbin MB£¬Melick J£¬et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res£¬2002£¬935(12) 40-46. 1.9 ¼¯Ìå×÷Õß [12] Diabetes Prevention Program Research Group. Hypertension£¬insulin£¬and proinsulin in participants with impaired glucose tolerance. Hypertension£¬2002, 40(5) 679-686. [13] ÖлªÒ½Ñ§»á¼ìÑéҽѧ·Ö»á. ¼ìÑé¿ÆÑÏÖØ¼±ÐÔºôÎü×ÛºÏÕ÷±ê±¾¼ì²â°²È«¹ÜÀíÖ¸ÄÏ(ÔÝÐÐ). Öлª¼ìÑéҽѧÔÓÖ¾£¬2003£¬26(5) 320-321. 1.10 ×÷ÕßδÊðÃû [14] 21st century heart solution may have a sting in the tail. BMJ£¬2002£¬325(7357) 184. 1.11 ͬһÆÚ¿¯Á¬ÔØ [15] ±±¾©ÊмìÑéѧ»á¼ÌÐø½ÌÓýίԱ»á. ÁÙ´²ÃâÒßѧ¼ìÑéÁ·Ï°Ìâ. Öлª¼ìÑéҽѧÔÓÖ¾£¬2002£¬25(5) 314-315;2002£¬25(6) 379-381. 1.12 µç×ÓÆÚ¿¯ [16] Abood S. Quality improvement initiative in nursing homes the ANA acts in an advisory role[JOL]. Am J Nurs£¬2002£¬102(6)23[2002-08-12]. http://www.nursingworld.org/AJN2002juneWawatch.htm. [17] ĪÉÙÇ¿. Êý×ÖʽÖÐÎÄÈ«ÎÄÎÄÏ׸ñʽµÄÉè¼ÆÓëÑо¿[JOL]. Ç鱨ѧ±¨£¬1999£¬18(4)1-6[2001-07-08]. http://periodical.wanfangdata.com.cn/periodical qbxbqbxb99qbxb9904990407.htm. [18] Íõ•D£¬ÓÚÏþÁᣬ³ÌÖ¾¸Õ. ¸ÎÔàÑ×ÐÔ¼ÙÁöµÄ³¬ÉùÔìÓ°±íÏÖ[JCD]. ÖлªÒ½Ñ§³¬ÉùÔÓÖ¾ µç×Ó°æ, 2006, 3(1). 1.13 ÒëÎÄ [19] Kinra S£¬Lewendon G£¬Nelder R£¬et al. »¯Ñ§ÆøÌåÎÛȾͻ·¢Ê¼þÖеÄÈËȺÊèÉ¢ ºá¶ÏÃæµ÷²é. ³ÂÀ×£¬Òë. Ó¢¹úҽѧÔÓÖ¾ÖÐÎİ棬2005£¬8(5) 285-288. 2 ÆÕͨͼÊé 2.1 Öø×÷»ò±àÖø ÖøÂ¼¸ñʽ£ºÖ÷ÒªÔðÈÎÕß. ÌâÃûÆäËûÌâÃûÐÅÏ¢[ÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±êÖ¾]. ÆäËûÔðÈÎÕß(ÀýÈç·­ÒëÕß). °æ±¾Ïî(µÚ1°æ²»ÖøÂ¼). ³ö°æµØ ³ö°æÕߣ¬³ö°æÄê ÒýÎÄÆðÒ³-Ö¹Ò³[ÒýÓÃÈÕÆÚ]. »ñÈ¡ºÍ·ÃÎÊ·¾¶. ×¢£ºÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±ê־Ϊµç×ÓÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿£¬ÒýÓÃÈÕÆÚ¡¢»ñÈ¡ºÍ·ÃÎÊ·¾¶ÎªÁª»úÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿¡£ [20] Íõ¼ÒÁ¼. ÁÙ´²Á÷Ðв¡Ñ§ ÁÙ´²¿ÆÑÐÉè¼Æ¡¢ºâÁ¿ÓëÆÀ¼Û. 2°æ. ÉϺ£ÉϺ£¿ÆÑ§¼¼Êõ³ö°æÉ磬2001. [21] Îâ½×ƽ£¬Ï®·¨×æ. »Æ¼ÒæáÍâ¿ÆÑ§. 6°æ. ±±¾© ÈËÃñÎÀÉú³ö°æÉ磬2002. [22] Murray PR£¬Rosenthal KS£¬Kobayashi GS£¬et al. Medical microbiology. 4th ed. St. Louis Mosby£¬2002. [23] ºö˼»Û. ÒûÉÅÕýÒª. Ó°Ó¡Ã÷¿Ì±¾. ÉϺ£ ÉϺ£¹Å¼®³ö°æÉ磬1990. [24] Íõ·òÖ®. ËÎÂÛ. ¿Ì±¾. ½ðÁê ÔøÊÏ£¬1865(ÇåͬÖÎËÄÄê). [25] Abrams WB£¬Beers MH£¬Berkow R. Ĭ¿ËÀÏÄ겡ÊÖ²á. ³Âå°Ö飬ÍõÔÞË´£¬ÁõºñîÚ£¬µÈ£¬Òë. 2°æ. ±±¾© ÈËÃñÎÀÉú³ö°æÉ磬1996 22-25. [26] ÕÔÒ«¶«. ÐÂʱ´úµÄ¹¤Òµ¹¤³Ìʦ[MOL]. ̨±± ÌìÏÂÎÄ»¯³ö°æÉ磬1998[1998-09-26]. http://www.ie.nthu.edu.tw/infoie.newie.htm(Big5). [27] Foley KM£¬Gelband H. Improving palliative care for cancer [MOL]. Washington National Academy Press£¬2001 [2002-07-09]. http://www.nap.edu/books0309074029html. [28] ÁÖ½­ÌÎ. Ö§Æø¹ÜÏø´­µÄÕï¶ÏÓëÖÎÁÆ[MDK]. ±±¾© ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉ磬2005. [29] ±±¾©ÊÐÉñ¾­Íâ¿ÆÑо¿Ëù.ÍõÖÒ³ÏÉñ¾­Íâ¿ÆÊÖÊõѧÊõϵÁжàýÌå½Ì³Ì[MCD]. ±±¾© ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉ磬2001. 2.2 Îö³öÎÄÏ× ÖøÂ¼¸ñʽ£ºÎö³öÎÄÏ×Ö÷ÒªÔðÈÎÕß. Îö³öÎÄÏ×ÌâÃû[ÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±êÖ¾] ׍ָÖ÷ÒªÔðÈÎÕß. ׍ָÌâÃû ÆäËûÌâÃûÐÅÏ¢. °æ±¾Ïî(µÚ1°æ²»ÖøÂ¼). ³ö°æµØ ³ö°æÕߣ¬³ö°æÄê Îö³öÎÄÏׯðÒ³-Ö¹Ò³[ÒýÓÃÈÕÆÚ]. »ñÈ¡ºÍ·ÃÎÊ·¾¶. ×¢£ºÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±ê־Ϊµç×ÓÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿£¬ÒýÓÃÈÕÆÚ¡¢»ñÈ¡ºÍ·ÃÎÊ·¾¶ÎªÁª»úÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿¡£ [30] Öî¿¥ÈÊ. »èØÊÓëÐݿ˶­³ÐÀÅ£¬ÌÕÊÙä¿£¬³Âå°Öé. ʵÓÃÐÄÔಡѧ. 3 °æ. ÉϺ£ÉϺ£¿ÆÑ§¼¼Êõ³ö°æÉ磬1993 561-585. [31] Meltzer PS£¬Kallioniemi A£¬Trent JM. Chromosome alterations in human solid tumorsVogelstein B£¬Kinzler KW. The genetic basis of human cancer. New York McGraw-Hill£¬2002 93-113. [32] µËСƽ. ¿ÆÑ§¼¼ÊõÊǵÚÒ»Éú²úÁ¦µËСƽ. µËСƽÎÄÑ¡µÚ3¾í. ±±¾© ÈËÃñ³ö°æÉ磬1993 274-276. [33] ³Â±ë. ÅÁ½ðÉ­²¡[MCD] ¼Ö½¨Æ½£¬ÕÅÐÂÇä. Éñ¾­ÏµÍ³¼²²¡ÕïÖνøÕ¹. ±±¾© ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉ磬2005. [34] Anderson SC£¬Poulsen KB. Andersons electronic atlas of hematology [MCD]. Philadelphia Lippincott Williams & Wilkins£¬2002. 3 »áÒéÎÄÏ× 
¾­¹ÜÖ®¼Ò¡°Ñ§µÀ»á¡±Ð¡³ÌÐò
  • ɨÂë¼ÓÈë¡°¿¼ÑÐѧϰ±Ê¼ÇȺ¡±
ÍÆ¼öÔĶÁ
¾­¼ÃѧÏà¹ØÎÄÕÂ
±êÇ©ÔÆ
¾­¹ÜÖ®¼Ò¾«²ÊÎÄÕÂÍÆ¼ö